The Effect of Shotblocker on Pain Violence and Injection Satisfaction

Launched by TC ERCIYES UNIVERSITY · Dec 9, 2022

Keywords

ClinConnect Summary

I Intervention Group: Before starting the application, the researcher informed the patients in the intervention group about the purpose of the study and their verbal and written informed consents were obtained.

The individuals to be included in the intervention and control groups were randomized by a faculty member at the Biostatistics Department of a university in the computer environment. The application was initiated by including the patients meeting the inclusion criteria on 04.12.2017. During the study, no intervention was made on the routine treatments of the patients in the interven...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Individuals whose treatment plan was Clexane 1x1 0.6 mg subcutaneous,
• • Who were over 18 years of age,
• • Who were conscious,
• • Who had cognitive competence to answer the questionnaire,
• • Who had no vision and hearing loss,
• • Who had no bleeding clotting disorder,
• • Who had platelet, INR and APTT values within normal limits,
• • Who had no signs of scar tissue, incision or infection in the injection site,
• • Who had no allergy history and agreed to participate in the study were included in the study.
• Exclusion Criteria:
• • The patients, who had amputation in the right/left arm region to be injected,
• • Who had any scar tissue, incision, lipodystrophy or infection symptom on the injection site in the arm area,
• • Who received hemodialysis treatment and had dialysis catheter,
• • Who underwent mastectomy surgery and should not receive any practice/treatment on the arm on the operated side, were excluded from the study.